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a b s t r a c t
Human rhinovirus and inﬂuenza virus infections of the upper airway lead to colds and the ﬂu and can
trigger exacerbations of lower airway diseases including asthma and chronic obstructive pulmonary
disease. Novel diagnostic and therapeutic targets are still needed to differentiate between the cold and
the ﬂu, since the clinical course of inﬂuenza can be severe while that of rhinovirus is usually more mild.
In our investigation of inﬂuenza and rhinovirus infection of human respiratory epithelial cells, we used a
systems approach to identify the temporally changing patterns of host gene expression from these
viruses. After infection of human bronchial epithelial cells (BEAS-2B) with rhinovirus, inﬂuenza virus or
co-infection with both viruses, we studied the time-course of host gene expression changes over three
days. We modeled host responses to these viral infections with time and documented the qualitative and
quantitative differences in innate immune activation and regulation.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Rhinovirus and inﬂuenza virus are among the leading causes of
infections of the upper respiratory tract and epithelial cells are usually
the initial targets of these viral infections (Eccles, 2005; Nichols et al.,
2008). The patterns of host responses evoked by each virus are
beginning to emerge. Recent in vitro studies have identiﬁed overall
changes as well as key host factors during inﬂuenza virus infection
(Watanabe et al., 2010; Shapira et al., 2009). In vivo studies on subjects
who were experimentally infected with rhinovirus (Proud et al., 2008)
or inﬂuenza (Woods et al., 2013) have identiﬁed host-derived changes
in gene expression and biological processes, and some of the ﬁndings
may have diagnostic potential (Zaas et al., 2013). Smith et al. (2012)
described 67 host biological pathways that were up-regulated in
common by seven different respiratory viruses including rhinovirus
and inﬂuenza by reviewing published data from a number of
laboratories. Zaas et al. (2009) developed gene expression signatures
from peripheral blood cells that distinguished individuals
experimentally infected with either rhinovirus, inﬂuenza virus, or
respiratory syncytial virus and more recently this group described a
RT-PCR based gene expression signature from blood cells that could
detect and discriminate between two types of inﬂuenza virus in
experimentally infected subjects (Zaas et al., 2013).
While classiﬁers of single virus infections would be clinically
valuable, especially if they are derived from multiple cell types and
different stages of infection, a given individual may be infected with
more than one virus. Indeed, Greer et al. (2009) and Casalegno et al.
(2010) reported that detection of rhinovirus was associated with a
reduced probability of detecting inﬂuenza virus in clinical samples.
In another co-infection study, 30 samples (13%) from individuals
infected with the inﬂuenza virus were positive by a PCR assay for 31
viral co-pathogens of which the most prominent was rhinovirus
(61%) (Esper et al., 2011). While co-infection may be common, more
recent studies found that disease severity and clinical course were
essentially similar in patients with co-infections compared to
patients with single infections (Choi et al., 2015; Asner et al., 2014;
Blyth et al., 2013; Navarro-Mari et al., 2012).
Several groups have studied gene expression changes in epithelial
cells after infection in vitro with rhinovirus [see Gene Expression
Omnibus (accession GSE55271, Schuler et al., 2014; accession
GSE28904, Naim et al. unpublished; accession GSE27973, Proud
et al., 2012) or inﬂuenza virus (Li et al., 2011; Mitchell et al., 2013;
Josset et al., 2014; see also accession GSE48466, Gerlach et al., 2013)],
but co-infection with both viruses in a well-controlled in vitro system
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has not been explored nor has an extensive time-course of host cell
transcriptional changes following viral infection of a respiratory cell
been investigated. Thus in order to better understand the host
respiratory cellular transcriptional response to either rhinovirus,
inﬂuenza virus and co-infection with both viruses, we performed a
detailed time-course analysis of transcriptional changes following
infection of the human bronchial epithelial cell line (BEAS-2B). From
this analysis, we detail the changes in host cell biological processes
and transcription that result from infection, including changes that
occur with co-infection of inﬂuenza and rhinovirus.
Results and discussion
Virus infections and derivation of differentially expressed genes
We evaluated the productivity, timing, and speciﬁcity of virus
infection by measuring two mRNAs speciﬁc for inﬂuenza virus, the
inﬂuenza A matrix protein 2 (M2) and non-structural protein 1 (NS;
accession Z21498), and an amplicon that was speciﬁc for the
rhinovirus 16 genome (accession EU096003). As shown in Fig. 1A,
viral speciﬁc gene expression was only observed in the appropriate
samples and changes in the expression of the viral speciﬁc genes
demonstrated that productive infections occurred. To conﬁrm the
expected host cellular response to rhinovirus and inﬂuenza virus
infection, we evaluated the temporal transcriptional proﬁles of
3 genes that were previously found to be up-regulated during
infection of epithelial cells by these viruses: ICAM1, the receptor for
rhinovirus 16 (Papi and Johnson, 1999); CXCL10, a chemokine for
monocytes and macrophages (Spurrell et al., 2005); and TLR3, an
intracellular receptor for double-stranded viral RNA (Hewson et al.,
2005; Guillot et al., 2005). Steady-state levels of these mRNAs were
strongly induced by viral infection as expected, but with several
virus speciﬁc differences as shown in Fig. 2. CXCL10 and TLR3 mRNA
levels peaked at 24 h, earlier after inﬂuenza infection compared to
rhinovirus infected cells, while ICAM1 mRNA levels were higher
after rhinovirus infection, raising the possibility that subtle viral
infection speciﬁc differences in regulation of these genes exist. As a
ﬁnal evaluation of the robustness of viral infection and the host cell
response to viral infection, we compared the mRNA and protein
changes for three cytokines that were previously shown to change
during respiratory virus infection in vitro as well as in vivo. As
shown in Supplementary File 3 steady-state mRNA levels for IL-6,
CXCL10 and CCL5 peaked at 48–60 h post-infection (depending on
the virus infection) while the levels of the corresponding proteins
secreted into the medium peaked 12–48 h later as expected for
simple transcriptional regulation. Finally, as a general validation of
the microarray results we reconﬁrmed the expression of three host
mRNAs that increased during the infection time-course (DDX60,
IFI27, SCD) and three mRNAs that decreased during the time-course
(CBX5, FBN2, EPCAM). Messenger RNA levels measured by RT-PCR
corresponded closely with the microarray results for each of these
mRNAs Supplementary File 4.
For our analysis of the microarray data, differentially expressed
genes from the BEAS-2B cells infected with rhinovirus (RV),
inﬂuenza virus (IV) or both viruses (RVþ IV) were derived by
comparison with mock-infected cells. Hierarchical cluster analysis
(not shown) revealed that relatively few host cell genes were
differentially expressed by 8 h post-infection. But by 24 h, the
expression of hundreds of genes was changing. Slightly more
genes were differentially expressed after IV infection compared
to RV infection at 24–36 h post-infection, but this pattern was
reversed by 48 h post-infection and at later times (Fig. 1B and C).
There were more up-regulated than down-regulated genes, and
down-regulated genes tended to lag up-regulated genes. Fig. 1D
compares the total number of unique host genes for each virus
infection. For example, 310 genes were up-regulated and 141 were
down-regulated in all three virus infections, while RV, IV and
RVþ IV speciﬁc and commonly up- and down-regulated genes
were also observed. Supplementary File 5 lists the differentially
expressed genes shown in Fig. 1D. These differentially expressed
genes were subsequently used for enrichment analysis and for the
derivation of pathways and networks.
The changing pattern of host cell responses after infection
Next, using the differentially up-regulated host genes from each
infection and at each time point, we derived a time-series map of
the changing pattern of biological processes, shown in Fig. 3. This
analysis demonstrated that some host cell pathways were common
to both viruses, including the RIG-I-like receptor (Entrez id: DDX58)
signaling pathway which senses cytoplasmic viral RNA, and other
Fig. 1. Differentially expressed host genes (FDR o0.01; log271.5). (A) Assay of inﬂuenza virus or rhinovirus amplicons. The levels of inﬂuenza-a M2 mRNA, inﬂuenza-a NS
mRNA, and an amplicon speciﬁc for the rhinovirus 16 genome were determined by qRT-PCR. (B) Up-regulated host genes relative to mock-infected cells; (C) down-regulated
host genes relative to mock-infected cells; (D) Venn diagram showing how the differentially expressed host genes overlap among the three virus infections. Uniquely
expressed up or down regulated genes were derived for each virus infection over all time points and compared. Red labels, up-regulated genes; blue labels, down-regulated
genes.
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innate immune sensing pathways including the NOD-like receptor
signaling pathway and other members of the toll-like receptor
signaling pathway. Inﬂuenza-speciﬁc pathways included steroid
biosynthesis, terpenoid backbone biosynthesis, pathways for glu-
tathione and purine biosynthesis and primary immunodeﬁciency.
Rhinovirus-speciﬁc pathways included cytokine and chemokine
signaling, p53 signaling, extracellular matrix-receptor interactions,
small cell lung cancer, cell adhesion/focal adhesion and B cell
receptor signaling. We next derived sub-sets of the differentially
expressed genes that were enriched over multiple sampling times
by the method of non-negative matrix factorization. Twenty pat-
terns or sub-sets of genes with deﬁned p-values (o0.01) and
consistent expression patterns were recognized as shown in
Supplementary File 6. This analysis revealed genes that were
expressed for a short period (i.e., one or two time points: patterns
7 or 10) and genes expressed for a long period (i.e., four or ﬁve time
points: patterns 1 or 2). The genes that comprised the former
patterns (5, 7, 10–14, 16–20) with continuous expression over
several time points (shown in Supplementary File 7) were adopted
for a more detailed pathway analysis. These ten gene groups are
presented in more detail in Fig. 4. For example pattern 1 was
deﬁned by 628 genes that were down-regulated after infection by
both viruses from 24 h through 72 h while the 52 genes in pattern
15 (Fig. 4A) were up- regulated late after rhinovirus infection. The
ten patterns illustrated in Fig. 4 encompassed over 1000 differen-
tially expressed genes that were either virus-speciﬁc or common to
both viruses. Expression information from these genes over the
72 h time course was used to illustrate diverse cellular processes
and to compose a comprehensive network for up-regulated host
genes in infected BEAS-2B cells as shown in Fig. 5. The group of
virus-speciﬁc and common networks summarized in Fig. 5 are
presented in detail at 2, 4, 8, 12, 24, 36, 48, 60, and 72 h post-
infection in Supplementary Files 8–16. Interferon responses were of
course induced by the RIG-1, NOD, and Toll receptor pathways (see
below).
The interferon response of BEAS-2B cells to viral infection
One pathway of speciﬁc interest to viral infection of cells is the
interferon response pathway. Thus we studied the expression of
the type 1 and 2 interferons, the interferon regulatory factors, and
fork-head family of transcription factors that have been implicated
as regulators of the interferon response. We evaluated the simple
normalized gene expression intensity values for members of these
gene families, rather than their differentially expressed values,
since low-level expression was important to document and would
otherwise have been ﬁltered out. IFNB1(interferon, beta-1) was
identiﬁed as the predominant type I interferon produced in BEAS-
2B cells following infection with either virus. Messenger RNAs for
other type I interferons (IFNA1, IFNE) and the type 2 interferon
IFNγ were not expressed above background (Fig. 6 and data not
shown). Among the family of interferon regulatory factors, IRF7
Fig. 2. Steady-state mRNA proﬁles for ICAM1, CXCL10, and TLR3. For all nine panels, the log2 ratio of the signal intensity of the indicated RNA for virus-infected cells relative
to mock infected (control) cells is plotted against time.
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and IRF9 were strongly up-regulated by both viruses. Both IRF7
and IRF9 mRNAs were induced 24-fold by inﬂuenza virus and
8-fold by rhinovirus, with a peak at 24–48 h post-infection. IRF1
mRNA was up-regulated after rhinovirus infection (about 8 fold)
but only about 2-fold by inﬂuenza virus. Messenger RNAs for IRF3
and other IRFs were not expressed above background levels. We
also proﬁled FoxO (fork-head box, subgroup O) family transcrip-
tion factors since FoxO3 has been implicated in the regulation of
IRF7 in murine macrophages (Litvak et al., 2012). Messenger RNAs
for FoxO1, FoxO3, and FoxO4 were induced by rhinovirus (but not
Fig. 3. Time-series map of the changing pattern of biological processes.
Fig. 4. Proﬁles of pattern genes: clustering analysis was performed by non-negative matrix factorization as described in Methods. (A) Early and late up-regulated
differentially expressed genes from IV, RV, or IVþRV infected cells. (B) Down-regulated differentially expressed genes from IV, RV, or IVþRV infected cells.
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inﬂuenza virus) above background with FoxO1the strongest,
showing a 2.6 fold induction at 48–60 h post-infection while
FoxO3 and FoxO4 were induced about 1.3 fold.
Host genes up-regulated by both viruses
Only a few differentially expressed mRNAs were detected as
early as 2–4 h after infection with either rhinovirus, inﬂuenza virus
or both viruses, but by 12 h post-infection many genes were up
regulated and in particular we noted the expression of genes
whose products comprise one of three initiating branches of the
innate immune system. One key part of innate immune activation
is based on detection of viral RNA in the cytosol (Hacker et al.,
2011). By 8 h-post-infection DDX58 and IRF9 were activated
(Supplementary File 10) and increased throughout the rest of the
study. The DDX58 gene product (also known as RIG-I) is a RNA
helicase which detects viral double strand RNA and thus infection
by inﬂuenza virus (and certain others), leading to one of the
earliest activation steps in innate immunity. After 12 h post-
infection (Supplementary File 11), genes from other members of
this family of viral receptors were detected including IFIH1
(interferon induced with helicase C domain 1; also known as
melanoma differentiation associated gene 5 or MDA5) and the
related gene DHX58 (also known as LGP2), whose product has
been reported to be a feedback inhibitor for antiviral signaling by
DDX58 and IFIH1 (Cui et al., 2001; Childs et al., 2012; Komuro and
Horvath, 2007). IFIH1 has also been reported to recognize ds-RNA
from replicating rhinovirus intermediates (Triantaﬁlou et al.,
2011). DDX58 and IFIH1 can interact with mitochondrial-antiviral
signaling protein (MAVS; also known as VISA) which was also
differentially expressed (data not shown), TRAF3, and IKBKE (both
shown on Fig. 5) leading to the induction of IRF3 (Xu et al., 2005;
Seth et al., 2005) and possibly contributing to induction of IRF7
and IRF9 which were much more strongly induced than IRF3 in
this study. The net result of this early signaling is the activation of
a group of interferon regulatory transcription factors IRF3, IRF7
and IRF 9, leading to production of interferon-β, the predominant
type I interferon that was produced in these BEAS-2B cells. The
viral RNA sensing pathway also activates production of pro-
inﬂammatory cytokines via NF-κB, STAT1 and STAT2 resulting in
a sustained anti-viral state for the cell. IRF7 and IRF9 are promi-
nent in this data and likely contribute to the induction of IFN-β
and CCL5, CXCL10, and CXCL11, which are all interferon inducible
cytokines (Nakano et al., 2012).
By 24 h post-infection (Supplementary File 12) our data shows
that TLR2 and TLR3 genes were active. A second innate immune
activation pathway derives from Toll-like receptors that signal
from the cell membrane. TLR2 is located in the plasma membrane,
recognizes the human rhinovirus 16 capsid (Triantaﬁlou et al.,
2011) and signals via myeloid differentiation factor 88 (MyD88),
and TRAF3 to activate proinﬂammatory cytokines via the NF-κB
and the JNK-p38 kinase pathways (Hacker et al., 2011). A third
branch of innate immune activation is based on TLR family
members that signal from endosomes. In BEAS-2B cells, TLR3
(Fig. 5) recognizes double-stranded RNA, resides in endosomal
vesicles, and it signals via TRIF, TRAF3, and IkBke to activate the
type 1 interferon response, NF-κB, and the JNK, p38 kinase path-
ways (Hacker et al., 2011). This report conﬁrms the study of
Hewson et al. (2005) which also noted the up-regulation of TLR3
in BEAS-2B cells after infection with rhinovirus.
By 8 h post-infection, in response to transcription by NF-κB, the
TNFAIP3 gene (tumor necrosis factor alpha induced protein 3)
becomes active. TNFAIP3 has been proposed to limit NF-κB
activation and to antagonize TNF-induced apoptosis by binding
to TRAF family adaptor proteins (Song et al., 1996; De Valck et al.,
1996; Heyninck et al., 1999). Also at 8 h post-infection, and in
Fig. 5. Summary of RV, IV, combined pathways. Virus perturbed signaling network. Hypothetical signaling pathway commonly enriched by both virus infections or
speciﬁcally enriched by inﬂuenza virus or rhinovirus infection are shown in middle/left/right side, respectively. Round node and diamond indicate gene product and
transcription factor, respectively. Pink color in node or in border is early up-regulation or late up-regulation, respectively. Sky blue line denotes the interaction between
transcription factor and its target gene. Solid or dashed black line is direct or indirect signaling protein interaction based on KEGG pathway. Dotted solid sky blue line shows
cellular/nucleus membrane.
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response to interferon binding, IRF9 becomes active, forming a
complex with STAT1 and STAT2 which speciﬁcally activates the
interferon program of gene expression that regulates the cellular
innate antiviral immune response and also inﬂuences adaptive
immunity (Biron, 2001; Samuel, 2001; Lau et al., 2003). By 12 h
post-infection, the chemokines CCL5, CXCL10 and CXCL11 become
active. CXCL10 and CXCL11 are chemo-attractants for monocytes
and macrophages and other immune cells. CCL5 (RANTES) is a
chemoattractant for T cells, eosinophils, and basophils. Also at 12 h
post-infection TNFSF10 (TRAIL) activity was induced by both
viruses. This cytokine in the TNF family can signal apoptosis via
its receptors DR4 (TRAIL-RI) and DR5 (TRAIL-RII) (Wiley et al.,
1995; Pitti et al, 1996).
In addition by 24 h post-infection, increasing NF-κB and STAT1-
STAT2-IRF9 activity may contribute to activation of antigen proces-
sing pathways ultimately leading to MHC I presentation of pro-
cessed viral antigens and activation of cytotoxic T cells. Among the
targets of these transcription complexes are genes whose products
activate the immune-proteosome that generates MHC class 1 anti-
gens and signal that the cell is infected. These genes include PSMB8
(proteasome subunit beta type-8), PSMB9, and PSMB10 that are
integral parts of the immune-proteosome (Bodmer et al., 1992;
Schmidt et al., 1999), or genes whose proteins contribute to its
regulation: PSME1 and PSME2 (Honore et al., 1994). TAP2 (protein
antigen transporter; Bahram et al., 1991), transports these peptides
from the cytoplasm to the endoplasmic reticulum so that they can
be presented by HLA-B, HLA-E and HLA-F molecules at the cell
membrane. Recently, Josset et al. (2014) showed that more patho-
genic serotypes of inﬂuenza A such as H7N9 do not induce the
antigen presentation pathway to the same degree as the less
pathogenic H1N1 strain used here.
Also up-regulated by IRF9-STAT1-STAT2 at 24 h post-infection,
particularly after inﬂuenza infection, are genes whose products
dephosphorylate purines (NT5E: 50-nucleotidase) or pyrimidines
(NT5C3: cytosolic 50-nucleotidase 3), degrade thymidine (TYMP,
thymidine phosphorylase), a 30-to-50 exoribonuclease (PNPT1 poly-
ribonucleotide nucleotidyltransferase 1), or cytidine (CMPK2, cyti-
dine monophosphate (UMP-CMP) kinase 2). Degradation of purines
would commonly result in generation of free energy e.g. ATP for
respiration and thus may be an indication of cell stress, starvation or
autophagy. Adenosine, another product of purine metabolism is
involved in suppression of the T effector response by inhibiting
production of NF-KB dependent cytokines. Conceivably, catabolism
of nucleic acids may permit the cell to prolong its survival in the face
of lethal inﬂuenza infection, and to indirectly defer or suppress an
overt T cell response.
Components of the complement cascade including C1S, C1R, and
the regulator CFH are also increased after inﬂuenza infection by
24 h post-infection. Greater up-regulation of complement compo-
nents could also be an indication of the robust, potentially lethal
early innate response triggered by inﬂuenza. The eventual outcome
of complement activation is likely activation of the membrane
attack complex that kills cells through lysis resulting in extensive
tissue damage and a massive ampliﬁcation of the innate response.
Two negative regulators of TNFα and NF-κB-induced inﬂamma-
tory responses also appeared at 24 h post-infection: TNFAIP3 and
BIRC3. TNFAIP3 inhibits NF-κB activation as well as TNFα-mediated
apoptosis by binding to TRAF family adaptor proteins (Heyninck
Fig. 6. Speculative feed forward loop for regulation of IFN. (A) Feed forward regulation of IFN-β can be mediated by a Fox family transcription factor that negatively regulates
an IRF transcription factor. (B) IFNB1, FOXO1, IRF7 and IRF9 may comprise such a system in BEAS-2B cells. (C) Simple steady-state mRNA levels for FoxO1 rise late, after peak
levels of IFNB1 and IRF7 in BEAS-2B cells, consistent with feed forward loop regulation.
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et al., 1999). BIRC3 (baculovirus IAP repeat-containing 3; Liston
et al., 1996; Rothe et al., 1996) can also bind to TRAF proteins, but it
could antagonize apoptosis via its E3 ubiquitin ligase, which is
speciﬁc for certain caspases including CASP7, an effector of apop-
tosis which was also up-regulated at 24 h post-infection.
By 36 h post-infection, IL-8 was up-regulated by both viruses. IL-8
is a strong chemoattractant for neutrophils and is a key mediator of
viral-induced bronchiolitis, or inﬂammation of respiratory tract tissues
(Baggiolini and Clark-Lewis, 1992). By 48 h post-infection, SOCS3 was
strongly up-regulated by both viruses. SOCS3 has been described as a
cytokine-induced negative regulator of cytokine signaling, in large
part because it can bind to JAK2 (Sasaki et al., 1999). JAK2 was up-
regulated after rhinovirus infection, but not inﬂuenza infection.
The interferon response of BEAS-2B cells to viral infection
Signaling from the RIG-1, NOD-like, Toll-like and other early
innate-immune pathways (Fig. 3) resulted in activation of inter-
feron responses (Fig. 5). Thus we studied the expression of the
type 1 and 2 interferons, the interferon regulatory factors, and
some members of the fork-head family of transcription factors that
have been implicated as interferon regulators. We evaluated the
simple normalized gene expression intensity values for members
of these gene families, in addition to their differentially expressed
values, since low-level expression was important to document and
would otherwise have been ﬁltered out. IFNB1(interferon, β-1)
was identiﬁed as the predominant type I interferon produced in
BEAS-2B cells following infection with either virus. Messenger
RNAs for other type I interferons (IFNA1, IFNE) and the type
2 interferon IFNγ were not expressed above background (Fig. 6
and data not shown). Among the family of interferon regulatory
factors, IRF7 and IRF9 were strongly up-regulated by both viruses.
Both IRF7 and IRF9 mRNAs were induced 24-fold by inﬂuenza
virus and 8-fold by rhinovirus, with a peak at 24–48 h post-
infection. IRF1 mRNA was up-regulated after rhinovirus infection
(about 8 fold) but only about 2-fold by inﬂuenza virus. Messenger
RNAs for IRF3 and other IRFs were not expressed above back-
ground levels. We also proﬁled FoxO (fork-head box, subgroup O)
family transcription factors since FoxO3 has been implicated in the
regulation of IRF7 in murine macrophages (Litvak et al, 2012).
Messenger RNAs for FoxO1, FoxO3, and FoxO4 were induced by
rhinovirus (but not inﬂuenza virus) above background with
FoxO1the strongest, showing a 2.6 fold induction at 48–60 h
post-infection while FoxO3 and FoxO4 were induced about 1.3 fold.
In BEAS-2B respiratory epithelial cells, the fork-head factors FoxO1,
FoxO3, and FoxO4 were expressed late, at 60–72 h post-infection,
consistent with a possible role in a coherent feed forward
regulatory loop linking IFN-β with either IRF7 or IRF9. Testing
whether any one or all three of these factors have an actual role in
the regulation of IRF7 or IRF9 in BEAS-2B epithelial cells is the
subject of a future study. In HEK293 and HeLa cells expressing IFN-
β, FoxO1 was described as a negative regulator of IRF3 (Lei et al.,
2013), while in murine macrophages FoxO3 was implicated as a
negative regulator of IRF7 (Litvak et al., 2012). The beneﬁcial
results of the interferon response such as inhibiting viral replica-
tion, removal of infected cells, and induction of the adaptive arm
of the immune system must be balanced by a mechanism to
control interferon levels to prevent an excessive response which
could lead to tissue damage.
Host genes up-regulated by rhinovirus
Fig. 2 shows that over 300 genes were speciﬁcally up-regulated by
rhinovirus. At 36 h post-infection, and later, several diverse
rhinovirus-speciﬁc genes were up-regulated including genes whose
products are part of the MAP kinase pathway (DUSP1, MAP4K4,
MR4A1 (60 h); the extracellular matrix-cellular receptor interactions
(COL4A6, LAMC2, COL4A1, LAMA3, ITGA5, ITGB8); the Wnt-frizzled
signaling pathway (FZD4, TCF7L1, MYC); the extended transforming
growth factor signaling network (EREG, BMP2, INHBA); cytokines and
growth factors (FGF2, IL1A, IL1B, CCL20, LIF, CD82); cell adhesion
molecules (L1CAM, CD276, CLDN1 (60 h). COL4A2 (common pathway)
and COL4A1 and COL4A6 (rhinovirus-speciﬁc) are all principal com-
ponents of the extracellular basement membrane that separates
epithelia from underlying tissues. LAMC2 and LAMA3 are key compo-
nents of laminin 5, a complex glycoprotein that forms ﬁlaments that
connect epithelial cells to the basement membrane (Mizushima et al.,
1998; Spirito et al., 2001). LIF andWnt signaling has been described as
synergistic at times, making independent but similar contributions to
cell fate, which signal a decision for self-renewal or to remain
undifferentiated (Ombrato et al., 2012). Our data suggests that LIF
was produced by the infected BEAS-2B cells, consistent with either
autocrine or paracrine signaling. The role of FZD4 in this system is less
clear since no wnt ligands were differentially expressed at any time.
Wnt ligands could of course arise from paracrine sources. Wnt-frizzled
signaling often occurs in conjunction with the β-catenin (CTNNB1)
pathway and β-catenin can bind to and negatively regulate TCF7L1
which may have effects on cell cycle regulation and cell senescence or
may inhibit differentiation of stem cells (Davidson, 2014). TCF7L1 may
also act as a repressor in the absence of β-catenin. Wnt signaling
typically also regulates cytoskeletal gene products, cell polarity, and
proliferation that might represent a restorative wound healing signa-
ture triggered later by rhinovirus. Genes with products that contribute
to glycosphingolipid biosynthesis (B4GALT1, B3GNT5, FUT4), and
arginine and proline metabolism (MAOA, SAT1, GLUL, CKMT1B) were
also expressed late in RV-infected cells.
By 48 h post-infection (Supplementary File 14) a group of genes
was identiﬁed that was up-regulated by rhinovirus but was down
regulated by inﬂuenza virus, demonstrating a clear difference between
the two viruses. Genes in this group included CLDN1, FGF2, IL1A, IL1B,
CCL20, and ID1. Caludin 1 (CLDN1) is a component of tight junctions
that are required for maintaining or restoring epithelial integrity.
CCL20 is strongly chemoattractant for lymphocytes but only weakly
for neutrophils. An early neutrophil response is triggered by inﬂuenza
virus but the intensity of this response is paramount since complete
depletion of neutrophils is also lethal. Essentially a balanced neutro-
phil response is needed for protection from inﬂuenza virus, since an
over-exuberant response was recently implicated as being key to
lethal inﬂuenza infection (Brandes et al., 2013). The fact that rhino-
virus uniquely triggers CCL20 might be an indicator that it is able to
evade massive neutrophil-mediated inﬂammation while harnessing
its protective effects. Concurrently, CCL20 is able to recruit lympho-
cytes and dendritic cells to the site of the infection. Dendritic cells
undergo maturation and migrate to the lymph nodes where an
effective adaptive response to rhinovirus may develop.
Host genes up-regulated by inﬂuenza virus
At late times post-infection, over 200 genes were speciﬁcally
up-regulated during inﬂuenza virus infection (Fig. 2 and
Supplementary Files 14–16). By 48 to 60 h post-infection, genes
that contribute to the biosynthesis of steroids or other lipids (SCD,
FADS2, ACSS2, C14orf1, MVK, FDFT1, DHCR7, DHCR24), genes that
contribute to oxidation and reduction chemistry (PCSK9, IFI30,
AKR1C3, ALDOC), and genes that are part of adenosine metabolism
(ADA) are up-regulated. Genes up-regulated by inﬂuenza, but
down-regulated by rhinovirus were also identiﬁed. These genes
included PPARGC1A (that encodes a transcriptional coactivator of
PPAR-γ that regulates genes with roles in energy metabolism),
PLAT, and ABCA1.
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Host genes up-regulated by rhinovirus and inﬂuenza virus co-
infection
Our study revealed that 132 genes were up-regulated and 310
genes were down- regulated after co-infection with both viruses,
based on our criteria of 1%FDR (FDRo0.01) and fold-change of
log 2 71.5 (Fig. 1D). The up-regulated genes returned GO terms
for regulation of cell proliferation, protein amino acid phosphor-
ylation, cell motility, phosphate metabolic processes, JAK-STAT
phosphorylation and signaling, cytokine signaling, and lympho-
cyte proliferation (po0.005). The 310 down-regulated genes
returned GO terms for other broad cellular processes such as
transcription, histone acetylation, RNA metabolism, and the cell
cycle (po0.007). The complete GO term lists along with repre-
sentative genes are presented in Supplementary File 17. Many of
the 132 and 310 genes were also expressed in the single-virus
infections (data not shown), but at levels that did not meet the
criteria for differential expression, suggesting that many of the
biological processes also pertained to the single virus infections.
A milder clinical course after rhinovirus infection?
Close comparison of the timing as well as the differentially
regulated sets of genes that comprise the host response to
infection by different viruses may point to differences in viral
pathogenesis that could help explain why clinical rhinovirus
infections are typically milder than inﬂuenza infections. Genes
associated with cell cycle control, apoptosis regulation, cell migra-
tion and tissue repair all emerge from this view of the data. We
speculate that the net effect of these processes may contribute to
an accelerated resolution of simple rhinovirus infections compared
to inﬂuenza infections.
For example, the p53 pathway was detected after rhinovirus
infection but not after inﬂuenza infection as shown in Fig. 3 simply
because rhinovirus-infected cells rather than inﬂuenza cells showed
more pathway genes differentially expressed starting early and con-
tinuing throughout the study. Consistent with the inﬂuenza literature,
apoptosis signaling via the p53 pathway does become active (Turpin et
al., 2005; Terrier et al., 2012; Nailwal et al., 2015), but more slowly than
infection by rhinovirus at least in the case of the BEAS-2B cells we
studied as shown in Supplementary File 18. This pathway is commonly
active after viruses infect mammalian cells, probably triggered by a
stress response, leading to cell cycle arrest at the G1 or G2 check points
as well as a commitment to apoptosis. Early cell cycle arrest would
inhibit early viral replication which may be reﬂected in the different
time course of rhinovirus and inﬂuenza replication we observed.
Rhinovirus replication was slower than inﬂuenza infection. Rhinovirus
replication increased slowly, peaking at 72 h post-infection, while
inﬂuenza replication peaked early and declined by 72 h (Fig. 1A). In
rhinovirus infected cells, p53 activation may also have initiated a non-
inﬂammatory form of apoptosis 12 h before inﬂuenza infected cells,
which would aid in clearance of the infected cell, without causing overt
inﬂammation. Supplementary File 18 visualizes the broad p53 pathway
and directly compares mRNA levels for key regulators from each virus
as a function of time. Increased transcription of PMAIP1 (or NOXA) was
detected 8–12 h after infection with rhinovirus but not by inﬂuenza
virus. PMAIP1 (NOXA) encodes a pro-apoptotic Bcl-2 homolog (Oda
et al, 2000) which may commit the cell to the intrinsic apoptosis
pathway very early post-infection. Other differentially expressed genes
include those leading to p53 phosphorylation (CHK2), those that
contribute to the outcomes of cell cycle arrest at G1 (14-3-3-a; cyclinD),
and others that like NOXA, may reinforce commitment to the intrinsic
apoptosis pathway: PUMA, SCOTIN, and PERP. A commitment to
apoptosis is also shown by differential expression of the FAS receptor
(FASR) and TNFRSF10A (Fig. 5; Supplementary File 18). FASR equips the
infected cell to respond to Fas ligand that could be presented by an
activated T cell, while TNFRSF10A, a member of the TNF receptor family
can transduce a cell death signal after activation by TNFSF10/TRAIL,
representing yet another path to apoptosis (Walczak et al., 1997; Pan et
al., 1997). This suggests that rhinovirus-infected BEAS-2B cells are also
primed for extrinsic initiation of programmed cell death since FAS-FASL
was differentially expressed by 48 h even while RV infection was
continuing to rise (Fig. 1A and Supplementary File 14). We speculate
that if apoptosis occurs before the release of virus particles, it could help
limit the spread of the infection. In contrast, inﬂuenza infection likely
triggers pyroptotic form of cell death that is more inﬂammatory and
less contained than simple apoptosis (Bergsbaken et al., 2009). Pyr-
optotic cell death is mediated by activation of caspase 1 that was
detected by 12 h post-infection (Supplementary File 11) resulting in
production of IL-1a and IL-1b, that while protective may also result in
tissue damage if unrestrained. Caspase 1 activation is largely mediated
through the NOD-like receptor signaling pathway that turns on after IV
infection rather than RV infection (Fig. 3). Supplementary File 18 shows
that inﬂuenza infection also activates genes in the intrinsic apoptosis
pathway, but with qualitative and temporal differences compared with
rhinovirus. Inﬂuenza virus may actively interfere with apoptosis.
Munoz-Fontela et al. (2011) infected p53-deﬁcient mice with inﬂuenza
virus and noted delayed cytokine and anti-viral gene responses in lung
and bone marrow as well as decreased dendritic cell activation and
virus-speciﬁc CD8 T cell immunity. But proteins induced by inﬂuenza
virus or respiratory syncytial virus stabilize p53 protein either by
interfering with MDM2-mediated ubiquitination (Wang et al., 2012)
or by inducing the G1 check point (Bian et al., 2012).
The suggestion that these two pathogens regulate apoptosis
differently is readily testable and could point to new thera-
peutic targets.
A second distinction of rhinovirus infected cells is suggested by the
up-regulation of the integrins ITGA5 and ITGB8 (Fig. 5). ITGA5 is a
receptor for ﬁbronectin and ﬁbrinogen, and it has also been linked to
the promotion of cell migration (Qin et al., 2011; Turner et al., 2008).
ITGB8 has a role in human airway epithelial proliferation while in the
brain it has been reported to alter the activation of Rho GTPases to
promote glioblastoma cell invasiveness (Reyes et al., 2013). These
integrins may enhance cell–cell and cell-extracellular matrix interac-
tions and play a role in epithelial proliferation (Kenny and Connelly,
2014) and contribute to efﬁcient presentation of viral antigens to
macrophages or dendritic cells which would then carry processed
antigens to the lymph nodes directing the adaptive immune response.
Cell–cell interactions are essential for rhinovirus infected cells to
present FasR at the cell membrane to Fas-L expressing cells, leading
to the removal of the FasR-expressing infected cells. A pro-migratory
role has also been proposed for MAP4K4 signaling (Fig. 5) which may
also contribute to the TNFα signaling cascade (Collins et al., 2006).
Rhinovirus-infected cells also launch tissue repair processes, espe-
cially directed towards the basement membrane. This is shown by the
differential expression of the non-ﬁbrillar collagens COL4A6, COL4A2,
and COL4A1 that are the principal collagens of the basement
membrane (Fig. 5). We speculate that during infectionwith rhinovirus,
some epithelial cells may repair or prevent damage to the basement
membrane, even if others are removed after apoptosis. The laminin
subunit gamma 2 is encoded by LAMC2 gene while the laminin alpha
3 chain is encoded by LAMA3 both of which were up-regulated in
rhinovirus infected cells (Fig. 5). Together they form laminin 5, which
is an integral part of the anchoring ﬁlaments that connect epithelial
cells to the underlying basement membrane and their up-regulation is
consistent with tissue repair or remodeling and cell migration
(Mizushima et al., 1998). Id1 expression was detected early, 2 and
4 h after rhinovirus infection (Supplementary Files 8 and 9). This basic
helix-loop-helix transcription factor appears to have a role in promot-
ing cell migration and proliferation (Nishiyama et al., 2005; Li et al.,
2004) which is consistent with a protective response triggered by
rhinovirus but not inﬂuenza virus. Very early expression of Id1 may
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prime the rhinovirus-infected cell for a potential survival response
early, before a potentially host-damaging innate response can start.
This might take the form of proliferation or migration to secondary
lymphoid organs where adaptive immunity could be triggered. Id1
expression becomes even stronger at late times for example 60 h
(Supplementary File 15) which may complement the other late
wound healing responses observed with rhinovirus.
The soluble factors produced in common after viral infection were
typically chemotactic, but rhinovirus-infected cells produced a broader
range of factors that illustrated the breadth of tissue repair and
remodeling that can be orchestrated by an epithelial cell. CCL5,
CXCL10, and CXCL11 mRNAs were differentially expressed by both
viruses and these are all chemotactic for T cells, with some activity to
attract eosinophils, basophils, monocytes, macrophages, and NK cells.
IL-15 and IL15RA were both differentially expressed in common as
well (Fig. 5). IL-15RA is the receptor that binds and presents IL-15 via
cell-to-cell contact or juxtacrine signaling to target cells (Jakobisiak et
al., 2011; Olsen et al., 2007) and it leads to proliferation and activation
of natural killer cells. IL8 was also produced after infection by both
viruses, and it is chemotactic for neutrophils, monocytes, and it can
induce phagocytosis activity. Substantially more diverse soluble fac-
tors were documented after rhinovirus infection that could contribute
to tissue repair or remodeling. Rhinovirus infection up-regulated IL-24
which can activate STAT1 and STAT3 in target cells and contribute to
wound healing (Wang and Liang, 2005). FGF2 (basic ﬁbroblast growth
factor) is a normal component of basement membranes and thus may
contribute to coordinating its repair (Ornitz and Itoh, 2001). The
broadly proinﬂammatory cytokines IL1A and IL1B were up-regulated
by rhinovirus, but not by inﬂuenza virus infection (Bankers-Fulbright
et al., 1996). Caspase 1 (CASP1) which activates the pro-protein of IL1B,
was up-regulated after rhinovirus infection or by rhinovirus plus
inﬂuenza virus. Rhinovirus infected cells also over-expressed CCL20,
which is chemotactic for lymphocytes and neutrophils (Hieshima et
al., 1997). The roles for several other factors produced after rhinovirus
infection are unclear (LIF, BMP2, EREG, INHBA), but may contribute to
repair or remodeling.
Limitations of the present analysis
The gene expression networks that are perturbed after an epithe-
lial cell line is infected by rhinovirus or inﬂuenza virus clearly
represents an oversimpliﬁcation of the complex biology that takes
place in vivo. First, we only investigated single types of rhinovirus and
inﬂuenza virus, H1N1. At a minimum, our results and conclusions only
pertain to these viral serotypes. Peripheral blood monocytes, macro-
phages, dendritic cells, and lymphocytes all respond to infecting
viruses directly, or to the cytokines and chemokines produced by
other infected cells, and those interactions were not part of this study.
Genes that were down-regulated during the time-course were
identiﬁed in Fig. 1 and listed in Supplementary File 3, but they were
not fully integrated into Fig. 5. Other genes that were deﬁned as
discrete subsets (Supplementary Files 6 and 7) but were only
expressed for 12–24 h were not integrated into the pathway time
course shown in Fig. 5. These gene subsets included some that were
speciﬁc for inﬂuenza (patterns 5, 7, 10, 11, 16, 19) and one that was
speciﬁc for rhinovirus (pattern 18). These short-time constant genes
were listed in Supplementary File 7. Integration of the down-
regulated and short time-constant genes will be the subject of a
future report. While we focused our study on inﬂuenza and rhino-
virus, additional viruses that infect respiratory epithelial cells are
known including respiratory syncytial virus, adenovirus, picornavirus,
or coronavirus (Duerkop and Hooper, 2013). Investigation of single or
co-infection of respiratory epithelial cells with these viruses in
addition to rhinovirus and inﬂuenza virus will provide us with a
greater understanding of the complexity of host response to respira-
tory infections. Inﬂuenza virus replicates early and rapidly triggers
inﬂammatory responses that would be likely to lead to substantial
tissue damage that may be slow to repair, while rhinovirus infection
results in a slower innate response, coupled with induction of wound
healing processes that may help achieve a level of inﬂammation that
is optimal to resolve infection while preventing wide-spread tissue
destruction. These possibilities await biological validation in suitable
gene knock-down and knock-out models in vitro and in vivo.
Materials and methods
Cell culture and viral infection
Human bronchial epithelial cells (BEAS-2B; ATCCs CRL-9609™)
were grown in Lonza (Cat# CC-3170) bronchial epithelial cell
growth medium in a 37 1C incubator with 5% CO2 and 90% humidity.
The day prior to RV16 infection, one 75 cm2 ﬂask of BEAS-2B cells
was treated with 2 ml of 0.25 mg/ml Trypsin /EDTA (Lonza, cat# CC-
5012) at 37 1C until the cells completely detached from the ﬂask
bottom. Then 6 ml of TNS (Trypsin Neutralizing Solution, Lonza cat#
CC-5002) were added to inactive the trypsin. The BEAS-2B cells
were transferred to a 15 ml tube and centrifuged for 5 min at
800 rpm; the supernatant medium was removed by aspiration, and
cells were re-suspended with 10 ml of the growth medium. The
BEAS-2B cells were counted using a Beckman Coulter Counter, and
diluted with growth medium to a density of 2.8105cells/ml.
BEAS-2B cells were seeded into 12-well plates at a density of
2.8105 cells/well and placed overnight in the 37 1C incubator
with 5% CO2 and 90% humidity. On the day of infection, the
rhinovirus strain RV16 (RV) and the inﬂuenza virus (IV) (H1N1,
strain A/WS/33, ATCC IV-1520) stocks were removed from a 80 1C
freezer, and diluted in serum-free medium. RV16 was chosen for
this work since it is approved by the FDA for human induced cold
studies and because it was used in a previous induced cold
transcriptomic study (Proud et al., 2008). The inﬂuenza A virus
strain H1N1 was chosen because it is a common cause of human ﬂu
and because the BEAS-2B cell line was shown to be permissive for
infection by both RV16 as well as inﬂuenza A virus strain H1N1
in vitro (Ueki et al., 2013). The results and conclusions we present
are thus limited to RV16 and inﬂuenza virus A, H1N1.
After removing the cell culture medium from the BEAS-2B cells,
300 μl of the diluted virus (either RV, IV or RVþ IV) was added to
each well. A similar volume of medium alone was added to the
control wells. A multiplicity of infection of 2 was used for each
virus. All plates were incubated at 33 1C with 5% CO2 and 90%
humidity. After a two hour incubation, 1.2 mls of the cell culture
mediumwere added to each well while 3 h later, the same amount
of medium was added to all other samples. All infected and
uninfected (control) samples were collected at the scheduled time
points (2, 4, 8, 12, 24, 36, 48, 60 and 78 h post-infection) and
processed according to a randomized schedule to minimize the
possibility of experimentally induced batch effects. Selected cyto-
kines were assayed in culture media at the indicated times with
the Milliplex Human Cytokine Magnetic Bead Panel Kits (Millipore,
Billerica MA USA).
RNA isolation and microarray data reduction
Total RNA (including small RNAs) was isolated from BEAS-2B cells
with QIAgen (Helden, Germany) miRNeasy Mini columns using the
manufacturer's protocol. In brief, monolayer BEAS-2B cells were rinsed
once with ice-cold phosphate buffered saline (pH 7.4) followed by
extraction in QIAzol lysis reagent and brief vortexing. Lysates were
frozen at 80 1C until RNA isolation. For RNA isolation, lysates were
thawed on ice and then extracted once in chloroform. Ethanol was
added to the aqueous phase of the extract and this mixture was added
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to RNeasy spin columns. Columns were washed to remove contami-
nants and puriﬁed total RNA was eluted with nuclease-free water.
RNA quantity was determined using a NanoDrop 8000 spectrophot-
ometer (Thermo Scientiﬁc, Waltham, MA). RNA quality and integrity
was conﬁrmed using the Agilent 2100 BioAnalyzer (Santa Clara, CA).
Puriﬁed RNA was stored at 80 1C until use in the Genechip
experiments. For the Genechip experiments, 250 ng of total RNA
was converted to Genechip targets using the Affymetrix HT 30 IVT
Express (Santa Clara, CA) protocol optimized for use on the Beckman
Coulter Biomek FXp automation workstation (Indianapolis, IN).
Labeled target was hybridized overnight to Affymetrix U219-96 plates
followed by washing, staining, and scanning on the Affymetrix
GeneTitan instrument following the manufacturer's protocol. To verify
the microarray results, selected mRNAs were quantitated by RT-PCR.
RT-PCR was performed with 1 μg of total RNA and the iScript cDNA
synthesis kit (Bio-Rad). A 1:20 dilution of cDNA was used in the RT-
PCR reaction. Quantitative RT-PCR was carried out in a 10 ml reaction
volume with gene-speciﬁc primers and β-actin using RT2 SYBR Green
ROX qPCR Mastermix (Qiagen). The qPCR conditions were 50 1C for
2 min, and 45 cycles of 95 1C for 15 s, 59 1C for 45 s, 72 1C for 30 s on
the ABI HT 7600 PCR instrument. All samples were assayed in
quadruplicate. The differences in expression of speciﬁc gene products
were evaluated using a relative quantiﬁcation method where the
expression of a speciﬁc cellular gene was normalized to the reference
gene, β-actin. For viral genes, the expression was compared to its
time-matched control sample. The primers used for veriﬁcation of
selected mRNAs from the microarray study and the viral RNAs are
listed in Supplementary File 1.
Bioinformatics analysis: The overall plan for the microarray data
analysis, calculation of differentially expressed genes and con-
struction of networks is outlined in Supplementary File 2, and
more details have been published (Cho et al., 2011; Brown et al.,
2014). The nine point time-course combined with four experi-
mental series (rhinovirus-infected; inﬂuenza-infected; infection
with both viruses; mock-infected) with ﬁve biological replicates
per time point generated 180 n.cel ﬁles for analysis. Pearson
correlations were calculated which revealed large changes in the
overall pattern of gene expression by 24 h, noticeable differences
between rhinovirus (RV) and inﬂuenza virus (IV) gene expression
starting by 12 h, and no outliers (data not shown). Differentially
expressed genes were calculated between the control and the
virus-infected samples and false-discovery rates were also calcu-
lated by our published methods. A false discovery rate of o0.01
and differential expression of log 2 71.5 were adopted for this
analysis. Differentially expressed genes were derived by compar-
ing infected cell proﬁles to mock infected proﬁles. We displayed
the overall time-course of expression by using hierarchical cluster
analysis (not shown). Instead of using heat maps for deﬁning sub-
sets of differentially expressed genes, we used a more objective
and comprehensive approach and derived subsets of differentially
expressed genes by a non-negative matrix factorization-based
clustering method (Kim et al., 2011; see also Hofree et al., 2013).
This clustering method not only allows us to automatically capture
dynamic gene expression patterns over multiple conditions, but it
also generates the protein sub-networks that correspond to the
captured dynamic patterns. In addition, since statistical values
such as p-values were computed and applied as a single statistical
test, we avoided applying multiple statistical tests which can
inﬂuence the false positive rate.
Functional enrichment analysis
To identify cellular processes for genes of interest, enrichment
analysis of gene ontology biological processes and KEGG pathways
was performed by using the Database for Annotation, Visualization
and Integrated Discovery (DAVID) v6.7 (Huang et al., 2009). The
biological processes signiﬁcantly (po0.01) enriched by the differ-
entially expressed genes identiﬁed at each time point were
summarized (see Results and discussion). The KEGG pathways that
were enriched by genes having speciﬁc temporal patterns of
expression were also derived (see Results and discussion). For
biological processes linked to multiple redundant terms, only the
most representative terms assigned to the largest numbers of
genes were chosen. Predicted interactions between transcription
factors and their potential target genes were identiﬁed from
GeneGO Metacore ver 6.7. In Metacore, the options ‘direct inter-
action’ and ‘transcriptional regulation’ were selected to retrieve
transcription factors and their targets.
Gene expression omnibus accession
The data from this study was placed in the GEO database under
accession GSE71766.
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